• CA-074: A Selective Cathepsin B Inhibitor Workflow

  2026-09-08

  CA-074 combines nanomolar cathepsin B potency with strong discrimination from cathepsins H and L, making it useful for separating CTSB-dependent phenotypes from broader lysosomal protease effects. This guide translates that selectivity into practical necroptosis, cancer metastasis, neurotoxicity, and immune-response workflows.

• Meropenem Workflows for Resistance Research

  2026-09-07

  Translate Meropenem activity into reproducible susceptibility, plasmid-transfer, and Gram-negative infection-model workflows. This guide connects β-lactam mechanism to carbapenemase surveillance while emphasizing fresh preparation, appropriate controls, and research-use limitations.

• Persistent rDNA Lesions and PML-Nucleolar Compartments

  2026-09-07

  Urbancokova, Hornofova, and colleagues identify persistent ribosomal DNA damage as a direct trigger of PML-nucleolar associations, linking topological stress, RNA polymerase I inhibition, and incomplete homologous recombination. The study provides a mechanistic framework for interpreting nucleolar reorganization and senescence after unresolved rDNA lesions.

• CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia

  2026-09-05

  Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback circuit linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and in vitro experiments position ATP, PKC, ERK1/2, and p38 MAPK as mechanistic components of a neuron–Merkel cell axis that may explain persistent touch-evoked pain in trigeminal neuralgia.

• Thiazovivin ROCK Inhibitor: Workflow Guide

  2026-09-04

  Thiazovivin is a ROCK inhibitor used to address cell-loss and reprogramming bottlenecks in induced pluripotent stem cell generation and human embryonic stem cell handling. This guide covers practical preparation, workflow integration, and QC using product-dossier information; it is not a substitute for cell-line-specific optimization and does not support diagnostic, therapeutic, or clinical use.

• EMD638683: From Target to Tissue Mechanics

  2026-09-04

  Explore how EMD638683, a selective SGK1 inhibitor, connects molecular target engagement with endothelial actin remodeling, vascular stiffness, and preclinical tumor biology. This evidence-centered guide explains assay design, selectivity limits, formulation, and how to interpret results across experimental systems.

• Prestained Protein Marker: Triple-Color Workflow

  2026-09-03

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible molecular-weight references for SDS-PAGE, transfer monitoring, and Western blot protein size verification. It is suitable for Phosbind SDS-PAGE and fluorescent membrane imaging, but it should not be treated as a quantitative mass standard or as a substitute for orthogonal protein characterization.

• Hagenia abyssinica Field Trial Against Biomphalaria

  2026-09-03

  This 2026 field study advances evaluation of Hagenia abyssinica flowers by combining molluscicidal testing against Biomphalaria snails with acute Nile tilapia toxicity assessment. Its central finding is that the plant fractions were active against snails, but fish were more sensitive to the 70% ethanol extract, emphasizing that efficacy and ecological selectivity must be evaluated together.

• Promethazine HCl: Macrophage Assay Workflows

  2026-09-02

  Promethazine HCl gives researchers a practical probe for connecting histamine H1 receptor biology with macrophage ROS, autophagy, and host-directed antibacterial responses. This guide translates phenothiazine research into controlled cell-based workflows, formulation choices, and troubleshooting strategies for reproducible immunology and signaling assays.

• QPRT, PLC Signaling, and Breast Cancer Invasion

  2026-09-02

  Liu et al. identify QPRT as a metabolic driver of breast cancer invasiveness and connect its activity to myosin light chain phosphorylation through purinergic, Rho/ROCK, PLC, and MLCK-associated signaling. The study provides a mechanistic framework for examining how NAD+ metabolism influences cytoskeletal motility, while also clarifying what PLC-directed experiments can and cannot establish.

• CXCL1-CXCR2 Signaling in Pancreatic Cancer Pain

  2026-09-01

  This study identifies the nucleus tractus solitarii as a central site where CXCL1-CXCR2 signaling activates microglia and amplifies pancreatic cancer-induced pain. Its combination of transcriptomics, behavioral testing, localized pharmacology, and gain- and loss-of-function experiments provides a mechanistic framework for studying brainstem neuroinflammation in visceral cancer pain.

• Bsa I (RNase-free): Practical Workflow Guide

  2026-09-01

  Bsa I (RNase-free) provides sequence-directed DNA cleavage for cloning and other molecular biology research workflows in which control of RNase contamination is important. It is intended for scientific research only, not diagnostic, clinical, or medical use, and reaction conditions should be validated for each DNA substrate.

• Midecamycin: Reading MIC Data by Mechanism

  2026-08-31

  Midecamycin is an acetoxy-substituted macrolide antibiotic whose ribosomal targeting and selective activity make it valuable for antibiotic research. This article connects chemical structure, historical MIC methods, resistance interpretation, and assay design into a practical framework for microbiology studies.

• Angiotensin I/II (1-5) Workflow Guide

  2026-08-31

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation and aldosterone release stimulation. It is suited to cardiovascular and renal workflows, but its water insolubility and lack of clinical validation limit use in unrelated signaling studies or therapeutic interpretation.

• Q-VD-OPh for Caspase Recovery Assays

  2026-08-30

  Q-VD-OPh is a cell-permeable pan-caspase inhibitor for separating caspase-driven death from post-stress recovery, anastasis, and assay-specific toxicity. This workflow combines controlled inhibitor exposure, orthogonal viability measurements, and the latest kinase-screen findings to improve apoptosis research, cryopreservation studies, and neurodegenerative disease experiments.

8068 records 2/538 page Previous Next 12345 下5页 Last page